Literature DB >> 1377139

Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats.

A Flyvbjerg1, U Kessler, B Dorka, B Funk, H Orskov, W Kiess.   

Abstract

The insulin-like growth factors, insulin-like growth factor I and insulin-like growth factor II are bound to six distinct classes of insulin-like growth factor binding proteins (IGFBPs) in the circulation and in extracellular fluids. Diabetic renal hypertrophy is preceded by a transient increase in kidney insulin-like growth factor I suggestive of a renotropic function for insulin-like growth factor I. In order to examine a possible involvement of IGFBPs in initial diabetic kidney growth and in kidney insulin-like growth factor I accumulation, we studied rat kidney IGFBPs by ligand blotting during the first 4 days after induction of diabetes. Six distinct bands were identified in kidney and liver tissue with apparent molecular weight values of 38-47 (doublet), 34, 30, 24 and 20 kDa. The 38-47 kDa doublet band probably corresponds to the insulin-like growth factor binding subunit of IGFBP-3, the 24 kDa band to IGFBP-4 and the 30 kDa band to IGFBP-1 and/or IGFBP-2, as these IGFBPs in rats have similar molecular weight. In untreated diabetic rats a transient increase in the kidney 30 kDa band was demonstrable 24 h after induction of diabetes with a maximal rise (two-fold) after 48 h, followed by a decrease to baseline values after 4 days. In untreated diabetic rats the 38-47 kDa doublet band also increased (two-fold) in kidney during the first 2 days after induction of diabetes, followed by a subsequent decrease. Insulin-treatment prevented both the increase in the 30 kDa and in the 38-47 kDa bands.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377139     DOI: 10.1007/bf00400489

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  9 in total

Review 1.  Insulin-like growth factor-binding proteins (IGFBPs): more than just 1, 2, 3.

Authors:  G T Ooi
Journal:  Mol Cell Endocrinol       Date:  1990-06-18       Impact factor: 4.102

2.  Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies.

Authors:  P Hossenlopp; D Seurin; B Segovia-Quinson; S Hardouin; M Binoux
Journal:  Anal Biochem       Date:  1986-04       Impact factor: 3.365

3.  Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats.

Authors:  A Flyvbjerg; K E Bornfeldt; S M Marshall; H J Arnqvist; H Orskov
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

4.  Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats.

Authors:  J Zapf; C Hauri; M Waldvogel; E Futo; H Häsler; K Binz; H P Guler; C Schmid; E R Froesch
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Identification of a type 1 insulin-like growth factor binding protein (IGF BP) in serum from rats with diabetes mellitus.

Authors:  T G Unterman; D T Oehler; R E Becker
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

6.  Regulation of hepatic expression of IGF I and fetal IGF binding protein mRNA in streptozotocin-diabetic rats.

Authors:  M Böni-Schnetzler; K Binz; J L Mary; C Schmid; J Schwander; E R Froesch
Journal:  FEBS Lett       Date:  1989-07-17       Impact factor: 4.124

7.  Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media.

Authors:  M A De Vroede; L Y Tseng; P G Katsoyannis; S P Nissley; M M Rechler
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

8.  Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells.

Authors:  O Ritvos; T Ranta; J Jalkanen; A M Suikkari; R Voutilainen; H Bohn; E M Rutanen
Journal:  Endocrinology       Date:  1988-05       Impact factor: 4.736

9.  Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions.

Authors:  W H Busby; D G Klapper; D R Clemmons
Journal:  J Biol Chem       Date:  1988-10-05       Impact factor: 5.157

  9 in total
  14 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Effects of long-acting somatostatin analogues on adrenal growth and phosphoribosyl pyrophosphate formation in experimental diabetes.

Authors:  Sirilaksana Kunjara; A Leslie Greenbaum; Milena Sochor; Murad Ali; Allan Flyvbjerg; Henning Grønbaek; Patricia McLean
Journal:  Int J Exp Pathol       Date:  2012-02       Impact factor: 1.925

3.  Coordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exercise.

Authors:  Benjamin F Miller; Jens L Olesen; Mette Hansen; Simon Døssing; Regina M Crameri; Rasmus J Welling; Henning Langberg; Allan Flyvbjerg; Michael Kjaer; John A Babraj; Kenneth Smith; Michael J Rennie
Journal:  J Physiol       Date:  2005-07-07       Impact factor: 5.182

4.  Differential modulation of mitogenic and metabolic actions of insulin-like growth factor I in rat glomerular mesangial cells in high glucose culture.

Authors:  R Kikkawa; M Haneda; M Togawa; D Koya; N Kajiwara; Y Shigeta
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

5.  Long-term renal changes in the liver-specific glucokinase knockout mouse: implications for renal disease in maturity-onset diabetes of the young 2.

Authors:  Yi Gu; Yiqing Mao; Hui Li; Shuyong Zhao; Yang Yang; Hui Gao; Jianqiang Yu; Xuemei Zhang; David M Irwin; Gang Niu; Huanran Tan
Journal:  Transl Res       Date:  2010-12-13       Impact factor: 7.012

6.  The accumulation of IGF-I in kidneys of streptozotocin-diabetic adult rats is not associated with elevated plasma GH or IGF-I levels.

Authors:  M Phillip; Y Segeve; A Zung; A A Kowarski; H Werner; C T Roberts; D Leroith; J Ladas; S E Mulroney
Journal:  Endocrine       Date:  1995-09       Impact factor: 3.633

7.  Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production.

Authors:  G Pugliese; F Pricci; N Locuratolo; G Romeo; G Romano; S Giannini; B Cresci; G Galli; C M Rotella; U Di Mario
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

8.  Increased hypothalamic-pituitary-adrenal axis activity and hepatic insulin resistance in low-birth-weight rats.

Authors:  Esben S Buhl; Susanne Neschen; Shin Yonemitsu; Joerg Rossbacher; Dongyan Zhang; Katsutaro Morino; Allan Flyvbjerg; Pascale Perret; Varman Samuel; Jung Kim; Gary W Cline; Kitt Falk Petersen
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-09-25       Impact factor: 4.310

9.  Ethinyl oestradiol administration in women suppresses synthesis of collagen in tendon in response to exercise.

Authors:  Mette Hansen; Satu O Koskinen; Susanne G Petersen; Simon Doessing; Jan Frystyk; Allan Flyvbjerg; Eva Westh; S Peter Magnusson; Michael Kjaer; Henning Langberg
Journal:  J Physiol       Date:  2008-04-17       Impact factor: 5.182

10.  Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats.

Authors:  H Grønbaek; B Nielsen; R Osterby; A Harris; H Orskov; A Flyvbjerg
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.